Ümit Aydoğan

732 total citations
61 papers, 528 citations indexed

About

Ümit Aydoğan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Ümit Aydoğan has authored 61 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Epidemiology. Recurrent topics in Ümit Aydoğan's work include Blood Pressure and Hypertension Studies (8 papers), Biomarkers in Disease Mechanisms (6 papers) and Chronic Kidney Disease and Diabetes (3 papers). Ümit Aydoğan is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Biomarkers in Disease Mechanisms (6 papers) and Chronic Kidney Disease and Diabetes (3 papers). Ümit Aydoğan collaborates with scholars based in Türkiye, United States and Serbia. Ümit Aydoğan's co-authors include Kenan Sağlam, Aydoğan Aydoğdu, Alper Sönmez, Oktay Sarı, Uğur Keskin, Cihangir Mutlu Ercan, James E. Rohrer, Erol Bolu, Özcan Uzun and İbrahim Alanbay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Archives of Pharmacal Research and International Journal of Pediatric Otorhinolaryngology.

In The Last Decade

Ümit Aydoğan

49 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ümit Aydoğan Türkiye 14 129 110 91 69 63 61 528
Ahmet Özgür Yeniel Türkiye 17 188 1.5× 32 0.3× 80 0.9× 188 2.7× 40 0.6× 70 931
Gonzalo R. Pérez‐Roncero Spain 14 122 0.9× 136 1.2× 24 0.3× 211 3.1× 31 0.5× 28 586
Efthymios Deligeoroglou Greece 16 271 2.1× 133 1.2× 87 1.0× 275 4.0× 65 1.0× 37 899
Liliana Gazzuola Rocca United States 13 119 0.9× 177 1.6× 23 0.3× 82 1.2× 17 0.3× 30 535
Michał Rabijewski Poland 14 91 0.7× 245 2.2× 55 0.6× 131 1.9× 10 0.2× 85 707
Marina Ivanišević Croatia 19 39 0.3× 224 2.0× 80 0.9× 171 2.5× 49 0.8× 84 1.2k
Teresa Baker United States 15 117 0.9× 52 0.5× 171 1.9× 314 4.6× 55 0.9× 45 734
Tao Ding United Kingdom 10 320 2.5× 64 0.6× 35 0.4× 259 3.8× 73 1.2× 26 639
Francisco J. Orejuela United States 15 141 1.1× 117 1.1× 15 0.2× 118 1.7× 31 0.5× 47 973

Countries citing papers authored by Ümit Aydoğan

Since Specialization
Citations

This map shows the geographic impact of Ümit Aydoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ümit Aydoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ümit Aydoğan more than expected).

Fields of papers citing papers by Ümit Aydoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ümit Aydoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ümit Aydoğan. The network helps show where Ümit Aydoğan may publish in the future.

Co-authorship network of co-authors of Ümit Aydoğan

This figure shows the co-authorship network connecting the top 25 collaborators of Ümit Aydoğan. A scholar is included among the top collaborators of Ümit Aydoğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ümit Aydoğan. Ümit Aydoğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydoğan, Ümit, et al.. (2024). Association Between Sleep Hygiene Parameters and Sleep Habits in 5- to 10-Year-Old School-Age Children. Clinical Pediatrics. 64(5). 616–630.
3.
Aydoğan, Ümit, et al.. (2022). Evaluation of Anemia and Related Factors in Pregnancy: A Cross-Sectional Study. SHILAP Revista de lepidopterología. 11(1). 61–69.
4.
Aytekіn, Gökhan, et al.. (2020). Symptoms and Awareness of Latex Allergy Among Healthcare Workers. 18(2). 73–81. 1 indexed citations
5.
Aydoğan, Ümit, et al.. (2020). Quality of Life and Associated Factors in Medical Students. 9(3). 154–162. 1 indexed citations
7.
Aydoğan, Ümit, et al.. (2016). Coping attitudes of cancer patients and their caregivers and quality of life of caregivers. Indian Journal of Palliative Care. 22(2). 150–150. 15 indexed citations
8.
Aydoğan, Ümit, et al.. (2015). Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis. Medical Principles and Practice. 24(4). 369–375. 16 indexed citations
9.
Aydoğan, Ümit, et al.. (2015). Predictors of Knowledge Level and Awareness towards Breast Cancer among Turkish Females. Asian Pacific Journal of Cancer Prevention. 16(1). 275–282. 15 indexed citations
10.
Rohrer, James E., et al.. (2015). Tonsillectomy, adenoidectomy and adenotonsillectomy rates in school-aged children: Relative contributions of socio-demographic and clinical features. International Journal of Pediatric Otorhinolaryngology. 79(7). 969–974. 9 indexed citations
11.
Rohrer, James E., et al.. (2015). Atherosclerosis and Liver Function Tests in Coronary Angiography Patients. West Indian Medical Journal. 64(4). 333–7. 5 indexed citations
12.
Aydoğan, Ümit, et al.. (2015). The prevalence and sociodemographic risk factors of enuresis nocturna among elementary school-age children. SHILAP Revista de lepidopterología. 4(1). 39–39. 20 indexed citations
13.
Ercan, Cihangir Mutlu, et al.. (2014). Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model. Archives of Gynecology and Obstetrics. 291(5). 1103–1111. 23 indexed citations
14.
Aydoğan, Ümit, et al.. (2014). Comparison of cystatin-C and pentraxin-3 in coronary atherosclerosis. Coronary Artery Disease. 25(7). 589–594. 3 indexed citations
15.
Aydoğdu, Aydoğan, İlker Taşçı, Serkan Tapan, et al.. (2012). High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology. 28(9). 722–725. 25 indexed citations
16.
Sarı, Oktay, Alpaslan Tanoğlu, Ümit Aydoğan, et al.. (2012). Serum visfatin levels before and after levothyroxin treatment in cases with hypothyroidism and subclinical hypothyroidism and their relationships between the lipid levels. Biomedical Research-tokyo. 23(1). 0. 2 indexed citations
17.
Aydoğan, Ümit, et al.. (2012). Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 12(4). 298–304. 26 indexed citations
18.
Iyısoy, Atila, et al.. (2012). The effect of valsartan and nebivolol treatment on ADMA and pentraxin-3 levels in hypertensive patients. Medical Hypotheses. 79(3). 294–298. 11 indexed citations
19.
Ercan, Cihangir Mutlu, Ümit Aydoğan, Kazım Emre Karaşahin, İbrahim Alanbay, & İskender Başer. (2011). Prolonged usage of intravaginal clindamycin cream combined with ampicillin for the management of PPROM - a case report. Journal of the Turkish-German Gynecological Association. 12(2). 124–126. 1 indexed citations
20.
Aydoğdu, Aydoğan, Gökhan Üçkaya, Abdullah Taşlıpınar, et al.. (2010). Calcaneal spur incidence is increased in patients with type 2 diabetes mellitus. 22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026